日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Estimating the prevalence of mental disorders in patients with newly diagnosed cancer in relation to socioeconomic status: a multicenter prospective observational study

评估新诊断癌症患者精神障碍患病率与社会经济地位的关系:一项多中心前瞻性观察研究

Goerling, U; Ernst, J; Esser, P; Haering, C; Hermann, M; Hornemann, B; Hövel, P; Keilholz, U; Kissane, D; von dem Knesebeck, O; Lordick, F; Springer, F; Zingler, H; Zimmermann, T; Engel, C; Mehnert-Theuerkauf, A

[Time-related perspectives on youth and the experiences of young people during times of COVID-19]

[关于青年时期及青年在新冠疫情期间经历的时间相关视角]

Berling-Ernst, A; Yahiaoui-Doktor, M; Kiechle, M; Engel, C; Lammert, J; Grill, S; Dukatz, R; Rhiem, K; Baumann, F T; Bischoff, S C; Erickson, N; Schmidt, T; Niederberger, U; Siniatchkin, M; Halle, M; Heyer, Lea

External ventricular drain infections: risk factors and outcome

脑室外引流管感染:危险因素和预后

Hagel, S; Bruns, T; Pletz, M W; Engel, C; Kalff, R; Ewald, C

Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)

评估ERCC4基因中与乳腺癌相关的候选SNP作为BRCA1和BRCA2突变携带者风险修饰因子的作用。来自BRCA1/BRCA2修饰因子研究联盟(CIMBA)的研究结果

Osorio, A; Milne, R L; Pita, G; Peterlongo, P; Heikkinen, T; Simard, J; Chenevix-Trench, G; Spurdle, A B; Beesley, J; Chen, X; Healey, S; Neuhausen, S L; Ding, Y C; Couch, F J; Wang, X; Lindor, N; Manoukian, S; Barile, M; Viel, A; Tizzoni, L; Szabo, C I; Foretova, L; Zikan, M; Claes, K; Greene, M H; Mai, P; Rennert, G; Lejbkowicz, F; Barnett-Griness, O; Andrulis, I L; Ozcelik, H; Weerasooriya, N; Gerdes, A-M; Thomassen, M; Cruger, D G; Caligo, M A; Friedman, E; Kaufman, B; Laitman, Y; Cohen, S; Kontorovich, T; Gershoni-Baruch, R; Dagan, E; Jernström, H; Askmalm, M S; Arver, B; Malmer, B; Domchek, S M; Nathanson, K L; Brunet, J; Ramón Y Cajal, T; Yannoukakos, D; Hamann, U; Hogervorst, F B L; Verhoef, S; Gómez García, E B; Wijnen, J T; van den Ouweland, A; Easton, D F; Peock, S; Cook, M; Oliver, C T; Frost, D; Luccarini, C; Evans, D G; Lalloo, F; Eeles, R; Pichert, G; Cook, J; Hodgson, S; Morrison, P J; Douglas, F; Godwin, A K; Sinilnikova, O M; Barjhoux, L; Stoppa-Lyonnet, D; Moncoutier, V; Giraud, S; Cassini, C; Olivier-Faivre, L; Révillion, F; Peyrat, J-P; Muller, D; Fricker, J-P; Lynch, H T; John, E M; Buys, S; Daly, M; Hopper, J L; Terry, M B; Miron, A; Yassin, Y; Goldgar, D; Singer, C F; Gschwantler-Kaulich, D; Pfeiler, G; Spiess, A-C; Hansen, Thomas V O; Johannsson, O T; Kirchhoff, T; Offit, K; Kosarin, K; Piedmonte, M; Rodriguez, G C; Wakeley, K; Boggess, J F; Basil, J; Schwartz, P E; Blank, S V; Toland, A E; Montagna, M; Casella, C; Imyanitov, E N; Allavena, A; Schmutzler, R K; Versmold, B; Engel, C; Meindl, A; Ditsch, N; Arnold, N; Niederacher, D; Deissler, H; Fiebig, B; Varon-Mateeva, R; Schaefer, D; Froster, U G; Caldes, T; de la Hoya, M; McGuffog, L; Antoniou, A C; Nevanlinna, H; Radice, P; Benítez, J

The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers

TP53 Arg72Pro 和 MDM2 309G>T 多态性与 BRCA1 和 BRCA2 突变携带者的乳腺癌风险无关。

Sinilnikova, O M; Antoniou, A C; Simard, J; Healey, S; Léoné, M; Sinnett, D; Spurdle, A B; Beesley, J; Chen, X; Greene, M H; Loud, J T; Lejbkowicz, F; Rennert, G; Dishon, S; Andrulis, I L; Domchek, S M; Nathanson, K L; Manoukian, S; Radice, P; Konstantopoulou, I; Blanco, I; Laborde, A L; Durán, M; Osorio, A; Benitez, J; Hamann, U; Hogervorst, F B L; van Os, T A M; Gille, H J P; Peock, S; Cook, M; Luccarini, C; Evans, D G; Lalloo, F; Eeles, R; Pichert, G; Davidson, R; Cole, T; Cook, J; Paterson, J; Brewer, C; Hughes, D J; Coupier, I; Giraud, S; Coulet, F; Colas, C; Soubrier, F; Rouleau, E; Bièche, I; Lidereau, R; Demange, L; Nogues, C; Lynch, H T; Schmutzler, R K; Versmold, B; Engel, C; Meindl, A; Arnold, N; Sutter, C; Deissler, H; Schaefer, D; Froster, U G; Aittomäki, K; Nevanlinna, H; McGuffog, L; Easton, D F; Chenevix-Trench, G; Stoppa-Lyonnet, D

A pharmacokinetic model of filgrastim and pegfilgrastim application in normal mice and those with cyclophosphamide-induced granulocytopaenia

在正常小鼠和环磷酰胺诱导的粒细胞减少症小鼠中应用非格司亭和培非格司亭的药代动力学模型

Scholz, M; Ackermann, M; Engel, C; Emmrich, F; Loeffler, M; Kamprad, M

Pharmacokinetic and pharmacodynamic modelling of the novel human granulocyte colony-stimulating factor derivative Maxy-G34 and pegfilgrastim in rats.

新型人粒细胞集落刺激因子衍生物 Maxy-G34 和培非格司亭在大鼠体内的药代动力学和药效学模型

Scholz M, Engel C, Apt D, Sankar S L, Goldstein E, Loeffler M

Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer)

林奇综合征(遗传性非息肉性癌症)临床管理指南

Vasen, H F A; Möslein, G; Alonso, A; Bernstein, I; Bertario, L; Blanco, I; Burn, J; Capella, G; Engel, C; Frayling, I; Friedl, W; Hes, F J; Hodgson, S; Mecklin, J-P; Møller, P; Nagengast, F; Parc, Y; Renkonen-Sinisalo, L; Sampson, J R; Stormorken, A; Wijnen, J

Educational technology in medical education

教育技术在医学教育中的应用

Engel, C E